 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/05/2025 |
$24.78 |
$24.83 |
$24.18 |
$24.30 |
806.70K | | 05/06/2025 |
$24.01 |
$24.18 |
$22.94 |
$23.06 |
1.25M | | 05/07/2025 |
$23.10 |
$23.59 |
$23.00 |
$23.46 |
1.34M | | 05/08/2025 |
$23.17 |
$23.17 |
$20.80 |
$22.76 |
2.68M | | 05/09/2025 |
$23.06 |
$23.70 |
$22.89 |
$23.37 |
1.55M |
|
|
| Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class medicines for rare and difficult-to-treat diseases. Its flagship product, FIRDAPSE (amifampridine) tablets, is approved for treating Lambert-Eaton Myasthenic Syndrome (LEMS) in adults and children aged six to seventeen. The company also markets FYCOMPA (perampanel) CIII for treating focal onset seizures and primary generalized tonic-clonic seizures in people with epilepsy. Additionally, its portfolio includes AGAMREE (vamorolone), an oral suspension for treating Duchenne Muscular Dystrophy (DMD), which is a corticosteroid treatment for DMD patients. | |
|
Catalyst Pharmaceuticals (CPRX) has the following price history information. Looking back at CPRX historical stock prices for the last five trading days, on May 05, 2025, CPRX opened at $24.78, traded as high as $24.83 and as low as $24.18, and closed at $24.30. Trading volume was a total of 806.70K shares. On May 06, 2025, CPRX opened at $24.01, traded as high as $24.18 and as low as $22.94, and closed at $23.06. Trading volume was a total of 1.25M shares. On May 07, 2025, CPRX opened at $23.10, traded as high as $23.59 and as low as $23.00, and closed at $23.46. Trading volume was a total of 1.34M shares. On May 08, 2025, CPRX opened at $23.17, traded as high as $23.17 and as low as $20.80, and closed at $22.76. Trading volume was a total of 2.68M shares. On May 09, 2025, CPRX opened at $23.06, traded as high as $23.70 and as low as $22.89, and closed at $23.37. Trading volume was a total of 1.55M shares.
CPRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalyst Pharmaceuticals shares, starting with a $10,000 purchase of CPRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/13/2015 |
|
| End date: |
05/09/2025 |
|
| Start price/share: |
$3.27 |
|
| End price/share: |
$23.37 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
614.68% |
|
| Average Annual Total Return: |
21.74% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$71,465.91 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 05/05/2025 | $24.30 | | 05/06/2025 | $23.06 | | 05/07/2025 | $23.46 | | 05/08/2025 | $22.76 | | 05/09/2025 | $23.37 |
|
|
Free CPRX Email Alerts:
